Samuel Abbate practices Endocrinology. He attended University of Illinois College of Medicine. He received awards:"Diabetes Recognition Program" and "Meaningful Use Stage 1 Certification". Dr. Samuel L. Abbate is also published. He has 1 publication published. The lastest publication: "Hyperglycemia predicts mortality after CABG: postoperative hyperglycemia predicts dramatic increases in mortality after coronary artery bypass graft surgery.' Samuel L. Abbate, MD accepts all Medicare patients.
NPI NUMBER | 1316953409 | |
NPPES Provider LastName | ABBATE | |
NPPES Provider FirstName | SAMUEL | |
NPPES Provider ZIPCode | 996547299 | |
NPPES Provider State | AK | |
Specialty Description | Endocrinology | |
Total Claim Count | 4637.0 | |
Distinct Opioid Count | 0.0 | |
Opioid Claim Count | 0.0 | |
Percent Opioid Claims | 0.0 |
National Provider Identifier [NPI] | 1316953409 |
Last Name Of The Provider | ABBATE |
First Name Of The Provider | SAMUEL |
View All |